Table 3.
Nature, mechanism, severity and etiology of AKI amongst participants.
| Variables | Total (%) | Male (%) | Female (%) | p |
|---|---|---|---|---|
| Nature | ||||
| Community acquired | 500 (93.30) | 278 (51.90) | 222 (41.40) | .099 |
| Hospital acquired | 36 (6.70) | 15 (2.80) | 21 (3.90) | |
| Mechanism | ||||
| Pre renal | 329 (61.40) | 195 (36.40) | 134 (25.00) | .004 |
| Acute tubular necrosis | 155 (28.90) | 84 (15.70) | 71 (13.20) | |
| Glomerular | 6 (1.10) | 2 (0.40) | 4 (0.70) | |
| Interstitial | 14 (2.60) | 3 (0.60) | 11 (2.00) | |
| Vascular | 10 (1.90) | 3 (0.60) | 7 (1.30) | |
| Obstructive | 22 (4.10) | 6 (1.10) | 16 (3.00) | |
| Severity AKI | ||||
| 1 | 176 (32.80) | 114 (21.30) | 62 (11.50) | .005 |
| 2 | 128 (23.90) | 65 (12.10) | 63 (11.80) | |
| 3 | 232 (43.30) | 114 (21.30) | 118 (22.00) | |
| Etiologies | ||||
| Sepsis/bacterial infection | 310 (50.40) | 173 (28.10) | 137 (22.30) | |
| Volume depletion | 195 (31.60) | 109 (17.70) | 86 (13.90) | |
| Nephrotoxins | 62 (10.10) | 40 (6.50) | 22 (6.40) | |
| Obstruction | 22 (3.60) | 5 (0.80) | 17 (2.80) | |
| Eclampsia/HELLP | 11 (1.80) | 0 (0.00) | 11 (1.80) | |
| Multiple Myeloma | 5 (0.80) | 3 (0.50) | 2 (0.30) | |
| Malignant hypertension | 5 (0.80) | 3 (0.30) | 2 (0.20) | |
| Systemic lupus | 3 (0.50) | 0 (0.00) | 3 (0.50) | |
| Lymphoma | 1 (0.20) | 1 (0.20) | 0 (0.00) | |
| Unknown | 1 (0.20) | 1 (0.20) | 0 (0.00) | |
Bold indicates the significant p values.